Billions of dollars that remain in the COVAX initiative, aimed at providing COVID-19 vaccines to the world’s poorest, could be redirected to prepare for future pandemics or to support vaccine manufacturing in Africa, according to the scheme’s partners. Implemented by Gavi, the Vaccine Alliance, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness …
Moderna has formally submitted its application for FDA authorization of its updated COVID-19 vaccine, designed to target the current dominant strain in the U.S. This latest version, the second update to the original vaccine, will provide protection specifically against the XBB.1.5 subvariant, rather than the ancestral Wuhan strain. Following the FDA’s guidance to vaccine manufacturers, …
In an update released on Friday, the Food and Drug Administration (FDA) instructed vaccine manufacturers to focus on targeting the XBB.1.5 strain of omicron for their fall COVID-19 update. According to the Centers for Disease Control and Prevention (CDC), the XBB.1.5 variant is currently responsible for approximately 40 percent of all infections. Vaccine companies have …